Abstract: Disclosed is a method for preparing (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, pharmaceutically acceptable salts, and pharmaceutically acceptable solvates thereof, such as the (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol hydrochloride salt via dynamic kinetic resolutions.
Type:
Application
Filed:
October 21, 2004
Publication date:
February 8, 2007
Applicant:
Smith Kline Beecham Corporation D/b/a Glaxo Smith Kline